Cistron Biotechnology(CIST)$.30 | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cistron Biotechnology(CIST)$.30

An SI Board Since October 1996

Posts	SubjectMarks	Bans	Symbol
2742	9	0	CIST

Emcee: harry zelatis	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
2517	THE STRONG INCOME FUNDS ---------------------------------------------------	Walter Morton	-	10/22/1999
2516	REPORT 13F REPORTING MANAGER: WEISS, PECK & GREER	Walter Morton	-	10/22/1999
2515	Trading volume when everybody was excited about CIST: siliconinvestor.com qui	Walter Morton	-	10/19/1999
2514	Do you recall what the volume was when CIST was trading around $1?	Walter Morton	-	10/15/1999
2513	Biochem Pharmacol, 58(7):1221-7 1999 Oct 1 The effect of macrophage supernata	Walter Morton	-	10/10/1999
2512	I'm surprised that I missed this: "In addition to the issued IL-1 pat	Walter Morton	-	10/9/1999
2511	-----Original Message----- From: Linda R. Watkins <lwatkins@psych.colorado.e	Walter Morton	-	10/8/1999
2510	Walter, you are confusing trials for wound healing and research into anti-virol	John Metcalf	-	10/8/1999
2509	The clinical trial was carried out at Fremantle Hospital, Western Australia, un	Walter Morton	-	10/8/1999
2508	OBJECTIVE: To study the expression and production of interleukin-1beta-converti	Walter Morton	-	10/8/1999
2507	BACKGROUND & AIMS: Fas-mediated apoptosis is one of the major death process	Walter Morton	-	10/8/1999
2506	Intraovarian interleukin-1 (IL-1), a putative intermediary in the ovulatory cas	Walter Morton	-	10/8/1999
2505	Thanks for the work, Walter. ICAM-1 is a target of ICOS, which has completed P	John Metcalf	-	10/8/1999
2504	September 1999 J Virol, 73(9):7193-8 1999 Sep Shafren DR; Gardner J; Mann VH; A	Walter Morton	-	10/8/1999
2503	From Skin & Allergy News Topical PAI-2 Seems to Improve Healing of Venous	Walter Morton	-	10/8/1999
2502	Please, explain to me how that news release relates to CIST and its shareholder	Walter Morton	-	10/8/1999
2501	In the event that Galton didn't sell the entire farm...... Thursday Octobe	scaram(o)uche	-	10/7/1999
2500	Interesting, but what about the low volume of trading in comparison to the 20+	Walter Morton	-	10/4/1999
2499	A few things I'd just put out there: "Increasing funded research&quo	Chris W.	-	10/4/1999
2498	Thanks John. However, the stock goes up and down all the time. Of the 20+ mil	Walter Morton	-	10/4/1999
2497	Walter, sorry for not responding to your last series of posts. Frankly, it'	John Metcalf	-	10/4/1999
2496	It seems that they are making some tough decisions to make the company profitab	Walter Morton	-	10/3/1999
2495	My take on reading the 10-K. It looks like the company is setting itself up to	Tom Bourbulas	-	10/1/1999
2494	CIST lost a few shareholders under the pressure: "On August 31, 1998, the	Walter Morton	-	9/30/1999
2493	<<These new IL-1 receptor antagonists are believed to be the first member	Walter Morton	-	9/30/1999

Go to reply# or date (mm/dd/yy):